Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Truncating the amyloid cascade hypothesis: the role of C-terminal Abeta peptides in Alzheimer's disease.

Teplow DB.

Neurobiol Aging. 1999 Jan-Feb;20(1):71-3; discussion 87. No abstract available.

2.
3.

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL.

Ann Neurol. 1999 Dec;46(6):860-6.

PMID:
10589538
4.

N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease.

Geddes JW, Tekirian TL, Mattson MP.

Neurobiol Aging. 1999 Jan-Feb;20(1):75-9; discussion 87. No abstract available.

PMID:
10466897
5.

Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome.

Head E, Garzon-Rodriguez W, Johnson JK, Lott IT, Cotman CW, Glabe C.

Neurobiol Dis. 2001 Oct;8(5):792-806.

PMID:
11592849
6.

Amyloid beta-peptide: the inside story.

Tseng BP, Kitazawa M, LaFerla FM.

Curr Alzheimer Res. 2004 Nov;1(4):231-9. Review.

PMID:
15975052
7.

Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.

Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA.

Neurobiol Aging. 2004 Nov-Dec;25(10):1263-72.

PMID:
15465622
8.
10.

The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease.

Catalano SM, Dodson EC, Henze DA, Joyce JG, Krafft GA, Kinney GG.

Curr Top Med Chem. 2006;6(6):597-608. Review.

PMID:
16712494
11.

The amyloid cascade hypothesis.

Korczyn AD.

Alzheimers Dement. 2008 May;4(3):176-8. doi: 10.1016/j.jalz.2007.11.008. Epub 2008 Apr 9.

PMID:
18631966
12.

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

Weller RO, Subash M, Preston SD, Mazanti I, Carare RO.

Brain Pathol. 2008 Apr;18(2):253-66. doi: 10.1111/j.1750-3639.2008.00133.x. Review.

PMID:
18363936
13.

The role of intracellular amyloid beta in Alzheimer's disease.

Li M, Chen L, Lee DH, Yu LC, Zhang Y.

Prog Neurobiol. 2007 Oct;83(3):131-9. Epub 2007 Aug 19. Review.

PMID:
17889422
14.

Animal models of the neuropathology observed in Alzheimer's disease and Down syndrome.

Richards SJ, Edwards P, Dunnett SB.

Prog Clin Biol Res. 1992;379:245-58. Review. No abstract available.

PMID:
1409748
15.

Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.

Head E, Azizeh BY, Lott IT, Tenner AJ, Cotman CW, Cribbs DH.

Neurobiol Dis. 2001 Apr;8(2):252-65.

PMID:
11300721
16.

Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease.

Golde TE, Dickson D, Hutton M.

Curr Alzheimer Res. 2006 Dec;3(5):421-30. Review.

PMID:
17168641
17.

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Hardy J, Selkoe DJ.

Science. 2002 Jul 19;297(5580):353-6. Review. Erratum in: Science 2002 Sep 27;297(5590):2209.

PMID:
12130773
18.

Amyloid imaging in Alzheimer's disease.

Nordberg A.

Neuropsychologia. 2008;46(6):1636-41. doi: 10.1016/j.neuropsychologia.2008.03.020. Epub 2008 Apr 8. Review.

PMID:
18468648
19.

Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.

Zhang YW, Xu H.

Curr Mol Med. 2007 Nov;7(7):687-96. Review.

PMID:
18045146
20.

Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.

Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, Laska E, Ehrlich ME, Walker LC, Mathews PM, Gandy S.

J Neurochem. 2004 Aug;90(4):1011-8.

Supplemental Content

Support Center